Cirrhosis screening

Cirrhosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cirrhosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Cirrhosis screening On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cirrhosis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cirrhosis screening

CDC on Cirrhosis screening

Cirrhosis screening in the news

Blogs on Cirrhosis screening

Directions to Hospitals Treating Cirrhosis

Risk calculators and risk factors for Cirrhosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:  Sudarshana Datta, MD [2]

## Overview

[edit | edit source]

Screening for hepatocellular carcinoma (HCC) must be done in every cirrhotic patient. It is performed at a frequency of 6-12 months. Screening endoscopy for detection of esophageal varices must be performed at regular intervals in all patients.

## Screening

[edit | edit source]

* Patients with cirrhosis must undergo screening for hepatocellular carcinoma (HCC) every 6-12 months.[1][2]
* Screening endoscopy for detection of esophageal varices must be performed:[3][4]
* Within a year in case of compensated cirrhosis
* Within three months in case of complicated cirrhosis

## References

[edit | edit source]

1. ↑ "Cirrhosis: Diagnosis, Management, and Prevention - American Family Physician".
2. ↑ Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M (2007). "Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?". Am. J. Gastroenterol. 102 (11): 2448–57, quiz 2458. doi:10.1111/j.1572-0241.2007.01395.x. PMID 17617210.
3. ↑ Heidelbaugh JJ, Bruderly M (2006). "Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation". Am Fam Physician. 74 (5): 756–62. PMID 16970019.
4. ↑ Qureshi W, Adler DG, Davila R, Egan J, Hirota W, Leighton J, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO (2005). "ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005". Gastrointest. Endosc. 62 (5): 651–5. doi:10.1016/j.gie.2005.07.031. PMID 16246673.

Template:WS Template:WH